These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 10962556

  • 1. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
    Wu CJ, Chen Z, Ullrich A, Greene MI, O'Rourke DM.
    Oncogene; 2000 Aug 17; 19(35):3999-4010. PubMed ID: 10962556
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
    Kapoor GS, Kapitonov D, O'Rourke DM.
    Cancer Res; 2004 Sep 15; 64(18):6444-52. PubMed ID: 15374953
    [Abstract] [Full Text] [Related]

  • 3. Negative regulation of hepatocellular carcinoma cell growth by signal regulatory protein alpha1.
    Yan HX, Wang HY, Zhang R, Chen L, Li BA, Liu SQ, Cao HF, Qiu XH, Shan YF, Yan ZH, Wu HP, Tan YX, Wu MC.
    Hepatology; 2004 Sep 15; 40(3):618-28. PubMed ID: 15349900
    [Abstract] [Full Text] [Related]

  • 4. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
    Tuck AB, Hota C, Wilson SM, Chambers AF.
    Oncogene; 2003 Feb 27; 22(8):1198-205. PubMed ID: 12606946
    [Abstract] [Full Text] [Related]

  • 5. The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells.
    Suárez Pestana E, Tenev T, Gross S, Stoyanov B, Ogata M, Böhmer FD.
    Oncogene; 1999 Jul 15; 18(28):4069-79. PubMed ID: 10435588
    [Abstract] [Full Text] [Related]

  • 6. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
    Wang Z, Wang M, Carr BI.
    J Cell Physiol; 2000 Jun 15; 183(3):338-46. PubMed ID: 10797308
    [Abstract] [Full Text] [Related]

  • 7. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
    Easton JB, Royer AR, Middlemas DS.
    J Neurochem; 2006 May 15; 97(3):834-45. PubMed ID: 16573649
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling.
    Chakravarti A, Loeffler JS, Dyson NJ.
    Cancer Res; 2002 Jan 01; 62(1):200-7. PubMed ID: 11782378
    [Abstract] [Full Text] [Related]

  • 9. PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells.
    Ghosh MK, Sharma P, Harbor PC, Rahaman SO, Haque SJ.
    Oncogene; 2005 Nov 10; 24(49):7290-300. PubMed ID: 16007122
    [Abstract] [Full Text] [Related]

  • 10. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
    Takahashi Y, Akanuma Y, Yazaki Y, Kadowaki T.
    J Cell Physiol; 1999 Jan 10; 178(1):69-75. PubMed ID: 9886492
    [Abstract] [Full Text] [Related]

  • 11. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ, O'Rourke DM, Feng GS, Johnson GR, Wang Q, Greene MI.
    Oncogene; 2001 Sep 20; 20(42):6018-25. PubMed ID: 11593409
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors.
    Karni R, Jove R, Levitzki A.
    Oncogene; 1999 Aug 19; 18(33):4654-62. PubMed ID: 10467412
    [Abstract] [Full Text] [Related]

  • 13. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.
    Charest A, Wilker EW, McLaughlin ME, Lane K, Gowda R, Coven S, McMahon K, Kovach S, Feng Y, Yaffe MB, Jacks T, Housman D.
    Cancer Res; 2006 Aug 01; 66(15):7473-81. PubMed ID: 16885344
    [Abstract] [Full Text] [Related]

  • 14. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
    Sawada M, Nakashima S, Banno Y, Yamakawa H, Takenaka K, Shinoda J, Nishimura Y, Sakai N, Nozawa Y.
    Oncogene; 2000 Jul 20; 19(31):3508-20. PubMed ID: 10918609
    [Abstract] [Full Text] [Related]

  • 15. SHP-2 regulates the phosphatidylinositide 3'-kinase/Akt pathway and suppresses caspase 3-mediated apoptosis.
    Ivins Zito C, Kontaridis MI, Fornaro M, Feng GS, Bennett AM.
    J Cell Physiol; 2004 May 20; 199(2):227-36. PubMed ID: 15040005
    [Abstract] [Full Text] [Related]

  • 16. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T, Lee HL, Cha JH, Ko SI, Kim HJ, Shin HI, Woo KM, Ryoo HM, Kim GS, Baek JH.
    J Cell Physiol; 2008 Nov 20; 217(2):409-22. PubMed ID: 18543257
    [Abstract] [Full Text] [Related]

  • 17. alphaPIX nucleotide exchange factor is activated by interaction with phosphatidylinositol 3-kinase.
    Yoshii S, Tanaka M, Otsuki Y, Wang DY, Guo RJ, Zhu Y, Takeda R, Hanai H, Kaneko E, Sugimura H.
    Oncogene; 1999 Oct 07; 18(41):5680-90. PubMed ID: 10523848
    [Abstract] [Full Text] [Related]

  • 18. The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner.
    Chakravarti A, Chakladar A, Delaney MA, Latham DE, Loeffler JS.
    Cancer Res; 2002 Aug 01; 62(15):4307-15. PubMed ID: 12154034
    [Abstract] [Full Text] [Related]

  • 19. Phosphatidylinositol 3'-kinase and SH2-containing inositol phosphatase (SHIP) are recruited by distinct positive and negative growth-regulatory domains in the granulocyte colony-stimulating factor receptor.
    Hunter MG, Avalos BR.
    J Immunol; 1998 May 15; 160(10):4979-87. PubMed ID: 9590246
    [Abstract] [Full Text] [Related]

  • 20. Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha.
    Stofega MR, Argetsinger LS, Wang H, Ullrich A, Carter-Su C.
    J Biol Chem; 2000 Sep 08; 275(36):28222-9. PubMed ID: 10842184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.